# data.medicaid.gov health datasets
* [Drug Utilization 1994 - Alabama](https://data.medicaid.gov/d/jbmv-qyyg) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [Drug Utilization 2011 - Alabama](https://data.medicaid.gov/d/6f3q-xete) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [Untitled Visualization - Based on State Medicaid and CHIP Applications, Eligibility Determinations, and Enrollment Data](https://data.medicaid.gov/d/gmmc-pbpb) - All states (including the District of Columbia) are required to provide data to The Centers for Medicare & Medicaid Services (CMS) on a range of indicators related to key application, eligibility, and enrollment processes within the state Medicaid and Children’s Health Insurance Programs (CHIP). These data reflect enrollment activity for all populations receiving comprehensive Medicaid and CHIP benefits in all states, as well as state program performance.
* [Drug Utilization 2008 - Alabama](https://data.medicaid.gov/d/fzsx-pevg) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [Drug Utilization 1993 - Alabama](https://data.medicaid.gov/d/a2ki-k9hp) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [Drug Utilization 2001 - Alabama](https://data.medicaid.gov/d/dnpy-9xhs) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [Drug Utilization 2005 - Alabama](https://data.medicaid.gov/d/b8p8-484k) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [Drug Utilization 1995 - Alabama](https://data.medicaid.gov/d/3dqw-kvfs) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [Drug Utilization 1999 - Alabama](https://data.medicaid.gov/d/59um-tgi9) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [DEV 2016](https://data.medicaid.gov/d/pvad-wnbw) - Performance rates on frequently reported health care quality measures in the CMS Medicaid/CHIP Child and Adult Core Sets, for FFY 2016 reporting. Source: Mathematica analysis of MACPro and Form CMS-416 reports for the FFY 2016 reporting cycle. For more information, see the <a href="https://www.medicaid.gov/medicaid/quality-of-care/performance-measurement/child-core-set/index.html">Children's Health Care Quality Measures</a> and <a href="https://www.medicaid.gov/medicaid/quality-of-care/performance-measurement/adult-core-set/index.html">Adult Health Care Quality Measures</a> webpages.
* [DEV](https://data.medicaid.gov/d/gzct-i8jv) - Performance rates on frequently reported health care quality measures in the CMS Medicaid/CHIP Child and Adult Core Sets, for FFY 2016 reporting. Source: Mathematica analysis of MACPro and Form CMS-416 reports for the FFY 2016 reporting cycle. For more information, see the <a href="https://www.medicaid.gov/medicaid/quality-of-care/performance-measurement/child-core-set/index.html">Children's Health Care Quality Measures</a> and <a href="https://www.medicaid.gov/medicaid/quality-of-care/performance-measurement/adult-core-set/index.html">Adult Health Care Quality Measures</a> webpages.
* [Drug Utilization 2012 - Alabama](https://data.medicaid.gov/d/3u34-tc7y) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [Delaware FY2016](https://data.medicaid.gov/d/ehs7-d6ev) - Performance rates on frequently reported health care quality measures in the CMS Medicaid/CHIP Child and Adult Core Sets, for FFY 2016 reporting.<br /><br />Source: Mathematica analysis of MACPro and Form CMS-416 reports for the FFY 2016 reporting cycle. For more information, see the <a href="https://www.medicaid.gov/medicaid/quality-of-care/performance-measurement/child-core-set/index.html">Children's Health Care Quality Measures</a> and <a href="https://www.medicaid.gov/medicaid/quality-of-care/performance-measurement/adult-core-set/index.html">Adult Health Care Quality Measures</a> webpages.
* [Drug Utilization 2003 - Alabama](https://data.medicaid.gov/d/qqtn-qm7v) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [WV 2016 Child Core Sets](https://data.medicaid.gov/d/eqh7-8vwz) - Performance rates on frequently reported health care quality measures in the CMS Medicaid/CHIP Child and Adult Core Sets, for FFY 2016 reporting.<br /><br />Source: Mathematica analysis of MACPro and Form CMS-416 reports for the FFY 2016 reporting cycle. For more information, see the <a href="https://www.medicaid.gov/medicaid/quality-of-care/performance-measurement/child-core-set/index.html">Children's Health Care Quality Measures</a> and <a href="https://www.medicaid.gov/medicaid/quality-of-care/performance-measurement/adult-core-set/index.html">Adult Health Care Quality Measures</a> webpages.
* [Drug Utilization 2009 - Alabama](https://data.medicaid.gov/d/pkad-k962) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [Drug Utilization 1997 - Alabama](https://data.medicaid.gov/d/tqxv-knmv) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [Drug Utilization 2000 - Alabama](https://data.medicaid.gov/d/fnw5-pqtc) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [Drug Utilization 2002 - Alabama](https://data.medicaid.gov/d/xjg8-r2m8) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [Drug Utilization 2004 - Alabama](https://data.medicaid.gov/d/f3hx-bdss) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [Drug Utilization 1992 - Alabama](https://data.medicaid.gov/d/adkh-bb5c) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [Drug Utilization 2007 - Alabama](https://data.medicaid.gov/d/buga-gh9h) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [GA Medicaid scores](https://data.medicaid.gov/d/g3gr-5bjj) - Performance rates on frequently reported health care quality measures in the CMS Medicaid/CHIP Child and Adult Core Sets, for FFY 2016 reporting. Source: Mathematica analysis of MACPro and Form CMS-416 reports for the FFY 2016 reporting cycle. For more information, see the <a href="https://www.medicaid.gov/medicaid/quality-of-care/performance-measurement/child-core-set/index.html">Children's Health Care Quality Measures</a> and <a href="https://www.medicaid.gov/medicaid/quality-of-care/performance-measurement/adult-core-set/index.html">Adult Health Care Quality Measures</a> webpages.
* [monthly enrollment data](https://data.medicaid.gov/d/3n2v-vtct) - All states (including the District of Columbia) are required to provide data to The Centers for Medicare & Medicaid Services (CMS) on a range of indicators related to key application, eligibility, and enrollment processes within the state Medicaid and Children’s Health Insurance Programs (CHIP). These data reflect enrollment activity for all populations receiving comprehensive Medicaid and CHIP benefits in all states, as well as state program performance.
* [Naloxone](https://data.medicaid.gov/d/eepp-vitq) - Active drugs that have been reported by participating drug manufacturers under the Medicaid Drug Rebate Program. All drugs are identified by National Drug Code (NDC), unit type, units per package size, product name, Food and Drug Administration (FDA) approval date, the date the drug entered the market, plus indicators to show whether the drug is an innovator or non-innovator drug; whether it is available by prescription or over-the-counter (OTC); the FDA therapeutic equivalency code; and the Drug Efficacy Study Implementation (DESI) rating and termination date.
* [ndc](https://data.medicaid.gov/d/nffd-xkzx) - Active drugs that have been reported by participating drug manufacturers under the Medicaid Drug Rebate Program. All drugs are identified by National Drug Code (NDC), unit type, units per package size, product name, Food and Drug Administration (FDA) approval date, the date the drug entered the market, plus indicators to show whether the drug is an innovator or non-innovator drug; whether it is available by prescription or over-the-counter (OTC); the FDA therapeutic equivalency code; and the Drug Efficacy Study Implementation (DESI) rating and termination date.
* [zDrugPricingAndPayment_Medicaid](https://data.medicaid.gov/d/syn6-aijv) - Active drugs that have been reported by participating drug manufacturers under the Medicaid Drug Rebate Program. All drugs are identified by National Drug Code (NDC), unit type, units per package size, product name, Food and Drug Administration (FDA) approval date, the date the drug entered the market, plus indicators to show whether the drug is an innovator or non-innovator drug; whether it is available by prescription or over-the-counter (OTC); the FDA therapeutic equivalency code; and the Drug Efficacy Study Implementation (DESI) rating and termination date.
* [lidocaine](https://data.medicaid.gov/d/w6nt-3m9s) - Active drugs that have been reported by participating drug manufacturers under the Medicaid Drug Rebate Program. All drugs are identified by National Drug Code (NDC), unit type, units per package size, product name, Food and Drug Administration (FDA) approval date, the date the drug entered the market, plus indicators to show whether the drug is an innovator or non-innovator drug; whether it is available by prescription or over-the-counter (OTC); the FDA therapeutic equivalency code; and the Drug Efficacy Study Implementation (DESI) rating and termination date.
* [Drug Utilization 2006 - Alabama](https://data.medicaid.gov/d/gpnj-f594) - Drug utilization data are reported by states for covered outpatient drugs that are paid for by state Medicaid agencies since the start of the Medicaid Drug Rebate Program. The data includes state, drug name, National Drug Code, number of prescriptions and dollars reimbursed. Data descriptions are available on Medicaid.gov: https://www.medicaid.gov/medicaid/prescription-drugs/state-drug-utilization-data/state-drug-utilization-data-faq/index.html
* [2017 10 Updated applications, eligibility determinations, and enrollment data](https://data.medicaid.gov/d/b53w-2dph) - All states (including the District of Columbia) are required to provide data to The Centers for Medicare & Medicaid Services (CMS) on a range of indicators related to key application, eligibility, and enrollment processes within the state Medicaid and Children’s Health Insurance Programs (CHIP). These data reflect enrollment activity for all populations receiving comprehensive Medicaid and CHIP benefits in all states, as well as state program performance.
* [Drug Product - 49502050002](https://data.medicaid.gov/d/2w6u-j96m) - Active drugs that have been reported by participating drug manufacturers under the Medicaid Drug Rebate Program. All drugs are identified by National Drug Code (NDC), unit type, units per package size, product name, Food and Drug Administration (FDA) approval date, the date the drug entered the market, plus indicators to show whether the drug is an innovator or non-innovator drug; whether it is available by prescription or over-the-counter (OTC); the FDA therapeutic equivalency code; and the Drug Efficacy Study Implementation (DESI) rating and termination date.
* [Drug Products - 2017 2Q](https://data.medicaid.gov/d/he94-rh4q) - Active drugs that have been reported by participating drug manufacturers under the Medicaid Drug Rebate Program. All drugs are identified by National Drug Code (NDC), unit type, units per package size, product name, Food and Drug Administration (FDA) approval date, the date the drug entered the market, plus indicators to show whether the drug is an innovator or non-innovator drug; whether it is available by prescription or over-the-counter (OTC); the FDA therapeutic equivalency code; and the Drug Efficacy Study Implementation (DESI) rating and termination date.
* [Clotting and Pediatric- 2017 Q3](https://data.medicaid.gov/d/rpt9-3kv6) - Active drugs that have been reported by participating drug manufacturers under the Medicaid Drug Rebate Program. All drugs are identified by National Drug Code (NDC), unit type, units per package size, product name, Food and Drug Administration (FDA) approval date, the date the drug entered the market, plus indicators to show whether the drug is an innovator or non-innovator drug; whether it is available by prescription or over-the-counter (OTC); the FDA therapeutic equivalency code; and the Drug Efficacy Study Implementation (DESI) rating and termination date.
* [Data suppressed](https://data.medicaid.gov/d/r5b6-58dj) - Performance rates on frequently reported health care quality measures in the CMS Medicaid/CHIP Child and Adult Core Sets, for FFY 2015 reporting. Source: Mathematica analysis of MACPro and Form CMS-416 reports for the FFY 2015 reporting cycle. For more information, see the <a href="https://www.medicaid.gov/medicaid/quality-of-care/performance-measurement/child-core-set/index.html">Children's Health Care Quality Measures</a> and <a href="https://www.medicaid.gov/medicaid/quality-of-care/performance-measurement/adult-core-set/index.html">Adult Health Care Quality Measures</a> webpages.
* [2018 02 Updated applications, eligibility determinations, and enrollment data](https://data.medicaid.gov/d/gcvk-pcqt) - All states (including the District of Columbia) are required to provide data to The Centers for Medicare & Medicaid Services (CMS) on a range of indicators related to key application, eligibility, and enrollment processes within the state Medicaid and Children’s Health Insurance Programs (CHIP). These data reflect enrollment activity for all populations receiving comprehensive Medicaid and CHIP benefits in all states, as well as state program performance.
* [2017 09 Updated applications, eligibility determinations, and enrollment data](https://data.medicaid.gov/d/a4df-6u2a) - All states (including the District of Columbia) are required to provide data to The Centers for Medicare & Medicaid Services (CMS) on a range of indicators related to key application, eligibility, and enrollment processes within the state Medicaid and Children’s Health Insurance Programs (CHIP). These data reflect enrollment activity for all populations receiving comprehensive Medicaid and CHIP benefits in all states, as well as state program performance.
